Quantitative molecular imaging of tumor biomarkers in vivo remains elusive due to the confounding effects of non-specific uptake. A multi-agent fluorescence tomography approach enables receptor concentration estimation in vivo, facilitating the study of drug-receptor interactions.

© 2016 Optical Society of America

PDF Article
More Like This
CT Tumor Sizing as a Quantitative Imaging Biomarker: When is Bias Relevant?

Nicholas Petrick, Rongping Zeng, Marios A Gavrielides, Qin Li, Berkman Sahiner, and Kyle J. Myers
QW1G.1 Quantitative Medical Imaging (QMI) 2013

Longitudinal Volumetric Assessment of Glioblastoma Brain Tumors in 3D Bio-Printed Environment by Mesoscopic Fluorescence Molecular Tomography

Mehmet S. Ozturk, Vivian K. Lee, Guohao Dai, and Xavier Intes
JM3A.46 Cancer Imaging and Therapy (Cancer) 2016

Pharmacokinetics model to assess the extravasation of tumor tissue by using fluorescence contrast agents

Ping Huang, Xavier Intes, Shoko Nioka, and Britton Chance
ThF9 Biomedical Topical Meeting (BIO) 2004